And in this paper, we revealed PIM1 to be promising for targeting at to wipe out CSC population specifically due to its regulation on RUNX3 cytoplasmic translocation, and inhibition of PIM1 could attenuate stem cell–like traits of breast cancer cells. Here, PIM1 is linked to breast cancer.